Diagnostic and prognostic role of protein and ultrastructural alterations at cell-extracellular matrix junctions in neoplastic progression of human oral malignancy.


Journal

Ultrastructural pathology
ISSN: 1521-0758
Titre abrégé: Ultrastruct Pathol
Pays: England
ID NLM: 8002867

Informations de publication

Date de publication:
03 Sep 2022
Historique:
pubmed: 2 9 2022
medline: 14 10 2022
entrez: 1 9 2022
Statut: ppublish

Résumé

Despite advancements in technology and increase in favorable outcomes associated with oral cancer, early detection remains the most significant factor in limiting mortality. The current study aimed to develop early diagnostic and prognostic markers for oral tumorigenesis. Protein and ultrastructural alterations at cell-extracellular matrix (ECM) adhesion junctions were examined concurrently using immunohistochemistry (IHC) and transmission electron microscopy (TEM) on progressive grade of oral carcinomas (n = 285). The expression of hemidesmosome (HD) proteins-integrin β4, BP180, and laminin-5 increased in hyperplasia as compared to normal, and significantly increased further, as the disease progressed. TEM analysis in parallel tissues revealed a significant decrease in HD number and increase in the length of basal lamina (BL) in hyperplasia. With cancer progression, the severity of ultrastructural alterations increased gradually and significantly. Overexpression of HD proteins, decrease in HD number and increase in BL length significantly correlated with nodal metastasis, local recurrence, and recurrence-free survival of patients. Concurrent use of IHC and TEM can add value to early recognition of neoplastic changes in primary carcinomas of oral cavity. In this regard, altered expression of integrin β4 and laminin-5, loss of HDs, and increased BL length could offer criteria for early diagnosis and prognosis of oral malignancy.

Identifiants

pubmed: 36049041
doi: 10.1080/01913123.2022.2114565
doi:

Substances chimiques

Integrin beta4 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

476-489

Auteurs

Harsh Nitin Dongre (HN)

Electron Microscopy Laboratory, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Kharghar, Navi Mumbai, India.
The Gade Laboratory for Pathology and Centre for Cancer biomarkers (CCBio), Department of Clinical Medicine, Faculty of Medicine, University of Bergen, Bergen, Norway.

Snehal Mahadik (S)

Electron Microscopy Laboratory, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Kharghar, Navi Mumbai, India.

Chetan Ahire (C)

Electron Microscopy Laboratory, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Kharghar, Navi Mumbai, India.

Pallavi Rane (P)

Epidemiology and Clinical Trials Unit, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Kharghar, Navi Mumbai, India.
Training School Complex, Homi Bhabha National Institute, Mumbai, India.

Shilpi Sharma (S)

Oral Surgery, Head and Neck Unit, Tata Memorial Hospital, Parel, Mumbai, India.

Fatima Lukmani (F)

Electron Microscopy Laboratory, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Kharghar, Navi Mumbai, India.

Asawari Patil (A)

Training School Complex, Homi Bhabha National Institute, Mumbai, India.
Department of Pathology, Tata Memorial Hospital, Parel, Mumbai, India.

Devendra Chaukar (D)

Training School Complex, Homi Bhabha National Institute, Mumbai, India.
Oral Surgery, Head and Neck Unit, Tata Memorial Hospital, Parel, Mumbai, India.

Sudeep Gupta (S)

Training School Complex, Homi Bhabha National Institute, Mumbai, India.
Department of Medical Oncology, Tata Memorial Hospital, Advanced Centre for Treatment, Research and Education in Cancer, Kharghar, Navi Mumbai, India.

Sharada Suhas Sawant (SS)

Electron Microscopy Laboratory, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Kharghar, Navi Mumbai, India.
Training School Complex, Homi Bhabha National Institute, Mumbai, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH